ClinicalTrials.Veeva

Menu

Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Adults with Chronic Disease

T

Tor Biering-Sørensen

Status

Active, not recruiting

Conditions

Influenza
Behavior and Behavior Mechanisms

Treatments

Behavioral: Behavioral Economic Principles

Study type

Interventional

Funder types

Other

Identifiers

NCT06600490
NUDGE-FLU-CHRONIC-2

Details and patient eligibility

About

In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. Conducted during the 2023/2024 influenza season, the first NUDGE-FLU-CHRONIC trial demonstrated the effectiveness of behavioral nudging letters in increasing influenza vaccination rates among adults aged 18-64 years with chronic diseases in Denmark. This present study will once again investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases including whether the effectiveness of the previously successful strategies can be confirmed during a subsequent influenza season.

Full description

The study is a prospective, randomized, open-label implementation trial. The study population will consist of persons aged 18-64 years identified as eligible for free-of-charge influenza vaccination due to a chronic condition. Subjects will be identified through Danish nationwide health registries using codes from the International Classification of Diseases, 10th revision (ICD-10). Individuals will be randomized to 1 of 7 arms (1 usual care arm and 6 intervention arms) with each testing different nudging strategies employing various behavioural economic principles. The interventions will be delivered through the official, mandatory Danish electronic letter system. All subject data will be retrieved from the Danish nationwide registries with the exception of information on intervention allocation. Endpoints will be retrieved at prespecified dates using prespecified search algorithms.

Enrollment

308,978 patients

Sex

All

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 18-64 years

  2. Must be registered in the Danish nationwide registries as meeting at least one of the following eligibility criteria for free-of-charge influenza vaccination in the Danish public health system:

    1. Chronic lung disease
    2. Chronic cardiovascular disease other than hypertension
    3. Type 1 or type 2 diabetes mellitus
    4. Congenital or acquired immunodeficiency
    5. Impaired breathing due to muscular weakness
    6. Chronic renal or hepatic insufficiency
    7. Other chronic conditions with an increased risk of severe influenza as determined by the treating physician
  3. Access to the official, mandatory Danish electronic mailbox system

Exclusion criteria

None

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

308,978 participants in 7 patient groups

Usual Care
No Intervention group
Description:
No letter
Standard Letter
Experimental group
Description:
This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement
Treatment:
Behavioral: Behavioral Economic Principles
Repeated Letter
Experimental group
Description:
The standard letter sent out two times instead of once
Treatment:
Behavioral: Behavioral Economic Principles
Cardiovascular Gain-Framing Letter
Experimental group
Description:
Text added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination
Treatment:
Behavioral: Behavioral Economic Principles
Repeated Cardiovascular Gain-Framing Letter
Experimental group
Description:
The cardiovascular gain-framing letter sent out two times instead of once
Treatment:
Behavioral: Behavioral Economic Principles
Respiratory Gain-Framing Letter
Experimental group
Description:
Text added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination
Treatment:
Behavioral: Behavioral Economic Principles
Implementation Intention Prompt Letter
Experimental group
Description:
Implementation intention prompt added to the standard letter
Treatment:
Behavioral: Behavioral Economic Principles

Trial contacts and locations

1

Loading...

Central trial contact

Niklas Dyrby Johansen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems